Semaphorin 3A promotes the long-term persistence of human SVF-derived microvascular networks in engineered grafts.

MLA

Schwager, Juan M., et al. “Semaphorin 3A Promotes the Long-Term Persistence of Human SVF-Derived Microvascular Networks in Engineered Grafts.” Frontiers in Bioengineering & Biotechnology, Sept. 2024, pp. 01-11. EBSCOhost, https://doi.org/10.3389/fbioe.2024.1396450.

APA

Schwager, J. M., Di Maggio, N., Grosso, A., Rasadurai, A., Minder, N., Hubbell, J. A., Kappos, E. A., Schaefer, D. J., Briquez, P. S., Banfi, A., & Burger, M. G. (2024). Semaphorin 3A promotes the long-term persistence of human SVF-derived microvascular networks in engineered grafts. Frontiers in Bioengineering & Biotechnology, 01-11. https://doi.org/10.3389/fbioe.2024.1396450

Chicago

Schwager, Juan M., Nunzia Di Maggio, Andrea Grosso, Abeelan Rasadurai, Nadja Minder, Jeffrey A. Hubbell, Elisabeth A. Kappos, et al. 2024. “Semaphorin 3A Promotes the Long-Term Persistence of Human SVF-Derived Microvascular Networks in Engineered Grafts.” Frontiers in Bioengineering & Biotechnology, September, 01-11. doi:10.3389/fbioe.2024.1396450.